Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program CMS launches an outcomes-based model to expand access to FDA-approved gene therapies for sickle ...

Short interest in bluebird bio Inc (NASDAQ:BLUE) increased during the last reporting period, rising from 2.41M to 2.42M. This put 26.93% of the company's publicly available shares short.

Blue Cloud Standalone September 2024 Net Sales at Rs 121.38 crore, up 202.06% Y-o-Y Nov 21 2024 10:00 AM Blue Cloud Consolidated June 2024 Net Sales at Rs 231.24 crore, up 570.37% Y-o-Y Aug 19 ...